Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kei Nakata
Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate After Acute Myocardial Infarction With Modification of Cardiac Metabolomes and Anti-Oxidants in Diabetic Rats.
Journal of Pharmacology and Experimental Therapeutics
Molecular Medicine
Pharmacology
Related publications
Atorvastatin Enhances Interleukin-10 Levels and Improves Cardiac Function in Rats After Acute Myocardial Infarction
Clinical Science
Medicine
Correction: Testosterone Deficiency Reduces the Effects of Late Cardiac Remodeling After Acute Myocardial Infarction in Rats
PLoS ONE
Multidisciplinary
Temporary Transvenous Cardiac Pacing in Patients With Acute Myocardial Infarction Predicts Increased Mortality
Cardiology Research
Cardiovascular Medicine
Cardiology
Predictors of Mortality After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
Angiology
Cardiovascular Medicine
Cardiology
Socioeconomic Differentials in Recurrent Ischaemia and Mortality After Acute Myocardial Infarction
Heart
Brain Natriuretic Peptide and Cardiac Rupture After Acute Myocardial Infarction.
Internal Medicine
Internal Medicine
Medicine
Albumin Excretion in Diabetic Patients in the Setting of Acute Myocardial Infarction: Association With 3-Year Mortality
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Heterogeneous Cardiac Sympathetic Innervation in Heart Failure After Myocardial Infarction of Rats
American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular Medicine
Physiology
Cardiology
Heart Rate on Admission Is an Independent Risk Factor for Poor Cardiac Function and In-Hospital Death After Acute Myocardial Infarction
Journal of Cardiology
Cardiovascular Medicine
Cardiology
